{
    "organizations": [],
    "uuid": "f66aff7ce694e836d13930a9f0191cdbdd89a62c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-shilpa-medicare-says-us-fda/brief-indias-shilpa-medicare-says-u-s-fda-issues-3-483-observations-to-cos-karnataka-units-idUSFWN1PH06X",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Shilpa Medicare Says U.S. FDA Issues 3 483 Observations To Co's Karnataka Units",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Shilpa Medicare Ltd:\n* US FDA COMPLETED INSPECTION OF COâ€˜S API FACILITIES UNIT-I AND UNIT-II LOCATED AT RAICHUR, KARNATAKA\n* SAYS INSPECTION CLOSED BY US FDA WITH THREE 483 OBSERVATIONS\n* IN PROCESS OF SUBMISSION OF CAPA PLAN TO REGULATOR WITHIN STIPULATED TIMELINES IN RESPONSE TO FORM 483 ISSUED Source text - bit.ly/2F0R0U9 Further company coverage:\n ",
    "published": "2018-01-22T16:55:00.000+02:00",
    "crawled": "2018-01-23T18:05:37.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shilpa",
        "medicare",
        "ltd",
        "u",
        "fda",
        "completed",
        "inspection",
        "co",
        "api",
        "facility",
        "located",
        "raichur",
        "karnataka",
        "say",
        "inspection",
        "closed",
        "u",
        "fda",
        "three",
        "observation",
        "process",
        "submission",
        "capa",
        "plan",
        "regulator",
        "within",
        "stipulated",
        "timeline",
        "response",
        "form",
        "issued",
        "source",
        "text",
        "company",
        "coverage"
    ]
}